(2021). Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”. Neuropsychopharmacology reports, 41(3), 266-324. https://doi.org/10.1002/npr2.12193
Chicago Style (17th ed.) Citation"Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”." Neuropsychopharmacology Reports 41, no. 3 (2021): 266-324. https://doi.org/10.1002/npr2.12193.
MLA (9th ed.) Citation"Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”." Neuropsychopharmacology Reports, vol. 41, no. 3, 2021, pp. 266-324, https://doi.org/10.1002/npr2.12193.
Warning: These citations may not always be 100% accurate.